YS-ON-002

N/A

Report date: 2024/11/08 15:30:27

Base Information

Drug NameYS-ON-002
Drug Alias NameYS-ON-002PIKA YS-ON-002
ClassificationBiologics
Mechanisms of ActionInterferon-induced helicase C domain-containing protein 1 inhibitorsRetinoic acid-inducible gene I inhibitorsToll like receptor 3 inhibitors
TargetsInterferon-induced helicase C domain-containing protein 1Retinoic acid-inducible gene IToll like receptor 3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLakeShore Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLakeShore Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A